HC Wainwright & Co. Maintains Buy on Adicet Bio, Lowers Price Target to $26
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Edward White maintains a 'Buy' rating on Adicet Bio (NASDAQ:ACET) but lowers the price target from $38 to $26.

August 11, 2023 | 10:28 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Adicet Bio's price target has been lowered from $38 to $26 by HC Wainwright & Co., though the 'Buy' rating is maintained.
The lowering of the price target by HC Wainwright & Co. could potentially lead to a short-term negative sentiment among investors. However, the maintained 'Buy' rating indicates that the analyst still sees potential in the company, which could balance out the negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100